Stock comparison

GILDvsNTRA

Gilead Sciences IncvsNatera Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

GILD

Gilead Sciences Inc

$133.64

+10.12%

Biotechnology$173.4BNASDAQ

NTRA

Natera Inc

$201.14

-11.94%

Biotechnology$28.0BNASDAQ

60-day price, rebased to 100

GILD -6.47% · NTRA -13.11%

Round-by-round

GILD 4·NTRA 2

EdgeGILD

Valuation upside

-27.50% vs -67.20% to DCF fair value

EdgeNTRA

Balance-sheet strength

Altman Z 4.47 vs 23.91

EdgeGILD

Fundamental quality

Piotroski 8.00 vs 5.00 (of 9)

EdgeNTRA

Growth + margins

Rule-of-40 34.50 vs 39.20

EdgeGILD

60-day momentum

-6.47% vs -13.11% price return

EdgeGILD

Market-cap liquidity

$173.4B vs $28.0B

Verdict

Across6categories,GILDtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onGILDorNTRA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.